New Panel-Agnostic Automated AML Diagnosis Solution Unveiled
A new diagnostic classification module for AHEAD Medicine's Cyto-Copilot platform enhances AML versus non-neoplastic classification.
A new diagnostic classification module for AHEAD Medicine's Cyto-Copilot platform enhances AML versus non-neoplastic classification.
Glut1 deficiency syndrome, or De Vivo Disease, is a rare and disabling neurological disease still relatively unknown to the medical community. And many are unaware that a simple blood test can now be used to diagnose it.
Flow cytometry labs are under pressure due to time, regulatory, and budgetary constraints, but there are ways to increase efficiency.
Cytek's Aurora CS delivers high-resolution capabilities at the single cell level to resolve and sort the most challenging cell populations.
The new European In Vitro Diagnostic Regulation is currently set to take effect in May 2022 and replaces the In Vitro Diagnostics Directive.
This kit has been developed specifically to address the pathogen detection and characterization challenges currently faced by laboratories around the world.